世界の閉経期の自律神経失調症治療市場:販売動向2018

【英語タイトル】Global Vasomotor Symptoms of Menopause Treatment Sales Market Report 2018

QYResearchが出版した調査資料(QYR8021900)・商品コード:QYR8021900
・発行会社(調査会社):QYResearch
・発行日:2017年12月29日
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、閉経期の自律神経失調症治療の世界市場について調査・分析し、閉経期の自律神経失調症治療のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、閉経期の自律神経失調症治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・閉経期の自律神経失調症治療市場概要
・閉経期の自律神経失調症治療のメーカー別販売量・メーカー別シェア
・閉経期の自律神経失調症治療の世界市場:種類別販売量・市場シェア
・閉経期の自律神経失調症治療の世界市場:用途別販売量・市場シェア
・閉経期の自律神経失調症治療の世界市場:地域別販売量・市場シェア
・閉経期の自律神経失調症治療のアメリカ市場規模
・閉経期の自律神経失調症治療の中国市場規模
・閉経期の自律神経失調症治療のヨーロッパ市場規模
・閉経期の自律神経失調症治療の日本市場規模
・閉経期の自律神経失調症治療の東南アジア市場規模
・閉経期の自律神経失調症治療のインド市場規模
・閉経期の自律神経失調症治療のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・閉経期の自律神経失調症治療のコスト分析・価格動向
・閉経期の自律神経失調症治療の産業チェーン(サプライチェーン分析)
・閉経期の自律神経失調症治療のマーケティング戦略・販売チャネル、流通業者
・閉経期の自律神経失調症治療市場への影響要因分析
・閉経期の自律神経失調症治療の世界市場予測
・閉経期の自律神経失調症治療のアメリカ市場予測
・閉経期の自律神経失調症治療の中国市場予測
・閉経期の自律神経失調症治療のヨーロッパ市場予測
・閉経期の自律神経失調症治療の日本市場予測
・閉経期の自律神経失調症治療の東南アジア市場予測
・閉経期の自律神経失調症治療のインド市場予測
・閉経期の自律神経失調症治療の種類別世界市場予測
・閉経期の自律神経失調症治療の用途別世界市場予測
...
【レポートの概要】

In this report, the global Vasomotor Symptoms of Menopause Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Vasomotor Symptoms of Menopause Treatment for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Vasomotor Symptoms of Menopause Treatment market competition by top manufacturers/players, with Vasomotor Symptoms of Menopause Treatment sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Amgen Inc.
EndoCeutics, Inc.
Euroscreen S.A.
MenoGeniX, Inc.
Mithra Pharmaceuticals S.A.
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
TherapeuticsMD, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Estetrol
Fezolinetant
FP-101
HBN-2
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Homecare
Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Vasomotor Symptoms of Menopause Treatment Sales Market Report 2017
1 Vasomotor Symptoms of Menopause Treatment Market Overview
1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment
1.2 Classification of Vasomotor Symptoms of Menopause Treatment by Product Category
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Vasomotor Symptoms of Menopause Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Estetrol
1.2.4 Fezolinetant
1.2.5 FP-101
1.2.6 HBN-2
1.2.7 Others
1.3 Global Vasomotor Symptoms of Menopause Treatment Market by Application/End Users
1.3.1 Global Vasomotor Symptoms of Menopause Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.4 Global Vasomotor Symptoms of Menopause Treatment Market by Region
1.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Vasomotor Symptoms of Menopause Treatment Status and Prospect (2012-2022)
1.4.3 China Vasomotor Symptoms of Menopause Treatment Status and Prospect (2012-2022)
1.4.4 Europe Vasomotor Symptoms of Menopause Treatment Status and Prospect (2012-2022)
1.4.5 Japan Vasomotor Symptoms of Menopause Treatment Status and Prospect (2012-2022)
1.4.6 Southeast Asia Vasomotor Symptoms of Menopause Treatment Status and Prospect (2012-2022)
1.4.7 India Vasomotor Symptoms of Menopause Treatment Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Vasomotor Symptoms of Menopause Treatment (2012-2022)
1.5.1 Global Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2022)
1.5.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2022)

2 Global Vasomotor Symptoms of Menopause Treatment Competition by Players/Suppliers, Type and Application
2.1 Global Vasomotor Symptoms of Menopause Treatment Market Competition by Players/Suppliers
2.1.1 Global Vasomotor Symptoms of Menopause Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Vasomotor Symptoms of Menopause Treatment (Volume and Value) by Type
2.2.1 Global Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type (2012-2017)
2.2.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Type (2012-2017)
2.3 Global Vasomotor Symptoms of Menopause Treatment (Volume and Value) by Region
2.3.1 Global Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Region (2012-2017)
2.3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Region (2012-2017)
2.4 Global Vasomotor Symptoms of Menopause Treatment (Volume) by Application

3 United States Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)
3.1 United States Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
3.1.1 United States Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
3.1.2 United States Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
3.1.3 United States Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)
3.2 United States Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Players
3.3 United States Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type
3.4 United States Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

4 China Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)
4.1 China Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
4.1.1 China Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
4.1.2 China Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
4.1.3 China Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)
4.2 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Players
4.3 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type
4.4 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

5 Europe Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)
5.1 Europe Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
5.1.1 Europe Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
5.1.2 Europe Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
5.1.3 Europe Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)
5.2 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Players
5.3 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type
5.4 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

6 Japan Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)
6.1 Japan Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
6.1.1 Japan Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
6.1.2 Japan Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
6.1.3 Japan Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)
6.2 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Players
6.3 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type
6.4 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

7 Southeast Asia Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)
7.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
7.1.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)
7.2 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Players
7.3 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type
7.4 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

8 India Vasomotor Symptoms of Menopause Treatment (Volume, Value and Sales Price)
8.1 India Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
8.1.1 India Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
8.1.2 India Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
8.1.3 India Vasomotor Symptoms of Menopause Treatment Sales Price Trend (2012-2017)
8.2 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Players
8.3 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Type
8.4 India Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share by Application

9 Global Vasomotor Symptoms of Menopause Treatment Players/Suppliers Profiles and Sales Data
9.1 Amgen Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 EndoCeutics, Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Euroscreen S.A.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 MenoGeniX, Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Mithra Pharmaceuticals S.A.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Pherin Pharmaceuticals, Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Pivot Pharmaceuticals Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Radius Health, Inc.
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 TherapeuticsMD, Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Vasomotor Symptoms of Menopause Treatment Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview

10 Vasomotor Symptoms of Menopause Treatment Maufacturing Cost Analysis
10.1 Vasomotor Symptoms of Menopause Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment
10.3 Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Vasomotor Symptoms of Menopause Treatment Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Vasomotor Symptoms of Menopause Treatment Market Forecast (2017-2022)
14.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2017-2022)
14.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Vasomotor Symptoms of Menopause Treatment Sales Forecast by Type (2017-2022)
14.3.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Forecast by Type (2017-2022)
14.3.3 Global Vasomotor Symptoms of Menopause Treatment Price Forecast by Type (2017-2022)
14.4 Global Vasomotor Symptoms of Menopause Treatment Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Vasomotor Symptoms of Menopause Treatment
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Estetrol Product Picture
Figure Fezolinetant Product Picture
Figure FP-101 Product Picture
Figure HBN-2 Product Picture
Figure Others Product Picture
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Global Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) by Regions (2012-2022)
Figure United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Vasomotor Symptoms of Menopause Treatment Sales Share by Players/Suppliers
Figure 2017 Vasomotor Symptoms of Menopause Treatment Sales Share by Players/Suppliers
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Players
Table 2017 Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Players
Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Type (2012-2017)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Growth Rate by Type (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Type (2012-2017)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate by Type (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Growth Rate by Region in 2016
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate by Region in 2016
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Region in 2016
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Application (2012-2017)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2012-2017)
Figure United States Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Players (2012-2017)
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players (2012-2017)
Figure United States Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players in 2016
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)
Figure United States Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)
Table United States Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)
Figure United States Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016
Figure China Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Players (2012-2017)
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players (2012-2017)
Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players in 2016
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)
Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)
Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)
Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players in 2016
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016
Figure Japan Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players (2012-2017)
Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players in 2016
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)
Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)
Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players in 2016
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016
Figure India Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Trend (2012-2017)
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Players (2012-2017)
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players (2012-2017)
Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Players in 2016
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2017)
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (2012-2017)
Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type in 2016
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2017)
Table India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application (2012-2017)
Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Application in 2016
Table Amgen Inc. Basic Information List
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table EndoCeutics, Inc. Basic Information List
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table Euroscreen S.A. Basic Information List
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table MenoGeniX, Inc. Basic Information List
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table Mithra Pharmaceuticals S.A. Basic Information List
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table Pherin Pharmaceuticals, Inc. Basic Information List
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table Pivot Pharmaceuticals Inc Basic Information List
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table Radius Health, Inc. Basic Information List
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table TherapeuticsMD, Inc. Basic Information List
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Growth Rate (2012-2017)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Global Market Share (2012-2017
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vasomotor Symptoms of Menopause Treatment
Figure Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment
Figure Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
Table Raw Materials Sources of Vasomotor Symptoms of Menopause Treatment Major Players in 2016
Table Major Buyers of Vasomotor Symptoms of Menopause Treatment
Table Distributors/Traders List
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast by Regions in 2022
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Regions in 2022
Figure United States Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

閉経期の自律神経失調症治療

★調査レポート[世界の閉経期の自律神経失調症治療市場:販売動向2018] (コード:QYR8021900)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の閉経期の自律神経失調症治療市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆